Seqex ELF-EMF Device

Seqex devices utilize extremely low frequency electromagnetic fields (ELF-EMF) within the Earth's natural magnetic range (1-124 Hz, 1-20 µT) to deliver non-invasive, ion-resonance therapy. This approach is customized via biofeedback testing, ensuring personalized programs stored on a patient card for clinic or home use. Sessions typically last 30-36 minutes, with no reported adverse effects across studies.

Reduces Perceived Depression Severity: In a 2022 double-blind study (n=20), 5 sessions led to statistically significant improvements in Zung Self-Rating Depression Scale (ZSDS) scores (from 48.6 to 37.8, p=0.012) and Beck Depression Inventory (BDI) scores (from 21.3 to 8.7, p=0.004), sustained at 2-month follow-up (ZSDS p=0.037; BDI p=0.04). This targets serotonin metabolism and inflammation-linked alterations.

Enhances Mental Well-Being: Short-Form 12 (SF-12) mental component scores improved significantly post-treatment (47.4 vs. 40.5 in placebo, p=0.048), indicating better quality of life, though follow-up showed partial retention.

Alleviates Chronic Pain: A 2007 study (n=143) on arthralgia and musculoskeletal disorders (e.g., rheumatoid arthritis, osteoporosis) reduced Numeric Rating Scale (NRS) pain scores from 8 to 2 after 10 sessions (p=0.000). Local probe application further accelerated relief (from 9 to 1).

Improves Joint Mobility & Reduces Analgesic Use: In geriatric osteoarthritis patients (n=10, 2018 study), pain at rest/motion dropped significantly (p=0.024/0.048), joint mobility improved by 75%, and as-needed analgesic intake was eliminated (p=0.018), with benefits lasting 4 months post-treatment.

Supports Osteonecrosis Recovery: A 2017 case report showed full remission of femoral head avascular necrosis (Ficat grade 1) after 4 months of twice-weekly sessions, confirmed by MRI at 12 months.

Reduces Inflammation & Oxidative Stress: Modulates systemic inflammation and lowers malondialdehyde (MDA) levels by 53.8% after 15 sessions in healthy volunteers (2007 study, p=0.0002), promoting anti-inflammatory effects without pharmaceuticals.

Enhances Microcirculation & Muscle Relaxation: Stimulates blood flow and induces relaxation, aiding recovery in peripheral joint disorders (e.g., 80% pain reduction after one session in valgus/arthritis cases, 2007).

Customized & Safe Application: Biofeedback identifies optimal frequencies/intensities (Adey's Window) for ion-resonance effects on cells, with variants like Seqex Med (clinic), Seqex Fam (home mat), and Seqex HC (portable) for total-body or focused cranial treatment.

These benefits position Seqex as a safe, evidence-based adjunct to integrative wellness, with CE marking, Health Canada Class II approval, and ISO-13485 certification. For depression specifically, it offers a low-risk alternative to higher-intensity TMS, with broad applicability for pain, stress, and overall vitality.